Raily Aesthetic Medicine International Holdings Limited announced unaudited consolidated earnings results for the six months ended 30 June 2021. For the period, revenue was RMB 91,492,000 against RMB 58,730,000 a year ago. Loss for the period was RMB 5,439,000 against RMB 11,777,000 a year ago. Basic and diluted loss per share attributable to ordinary equity holders of the parent were 0.25 cents against 0.70 cents a year ago.